Calreticulin, a Potential Vascular Regulatory Protein, Reduces Intimal Hyperplasia After Arterial Injury

Overview of attention for article published in Arteriosclerosis, Thrombosis, and Vascular Biology (Highwire), November 1997

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Modulation of efferocytosis pathways for treatment of atherosclerotic disease

Grant US-10329354-B2

United States of America

25 Jun 2019

MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

Application EP-3046627-A4

European Patent Office

30 Aug 2017

Method of inhibiting the generation of active thrombin on the surface of a cell within an…

Grant US-7524826-B2

United States of America

28 Apr 2009

Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and…

Grant US-7488711-B2

United States of America

10 Feb 2009

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.